Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation

Nature Medicine

Volumn 15, Issue 4, 2009, Pages 436-441

  Morris, Edward S ^a   MacDonald, Kelli P A ^a   Kuns, Rachel D ^a   Morris, Helen M ^a   Banovic, Tatjana ^a   Don, Alistair L J ^a   Rowe, Vanessa ^a   Wilson, Yana A ^a   Raffelt, Neil C ^a   Engwerda, Christian R ^a   Burman, Angela C ^a   Markey, Kate A ^a   Godfrey, Dale I ^b   Smyth, Mark J ^c   Hill, Geoffrey R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL STIMULATION; CLINICAL STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DONOR; EUROPE; FEMALE; GRAFT VERSUS HOST REACTION; HOST CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; NORTH AMERICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGISTER; UPREGULATION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MODELS, ANIMAL; NEUTROPHILS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 64149127331     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1948     Document Type: Article

References (30)

1. Morris, E.S., MacDonald, K.P. & Hill, G.R. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL? Blood 107, 3430-3435 (2006).
2. Ringden, O. et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 22, 416-423 (2004).
3. Khoury, H.J. et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 107, 1712-1716 (2006).
4. Klumpp, T.R., Mangan, K.F., Goldberg, S.L., Pearlman, E.S. & Macdonald, J.S. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J. Clin. Oncol. 13, 1323-1327 (1995).
5. McQuaker, I.G. et al. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphopro l iferative disorders: evidence for clinical and economic benefit. J. Clin. Oncol. 15, 451-457 (1997).
6. Pagliuca, A., Carrington, P.A., Pettengell, R., Tule, S. & Keidan, J. Guidelines on the use of colony-stimulating factors in haematological malignancies. Br. J. Haematol. 123, 22-33 (2003).
7. Morris, E.S. et al. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs. J. Clin. Invest. 115, 3093-3103 (2005).
8. Patterson, S. et al. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors. J. Immunol. 181, 3268-3276 (2008).
9. Liu, F., Wu, H.Y., Wesselschmidt, R., Kornaga, T. & Link, D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491-501 (1996).
10. Shlomchik, W.D. et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285, 412-415 (1999).
11. Ochando, J.C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7, 652-662 (2006).
12. Merad, M. et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10, 510-517 (2004).
13. Hill, G.R. & Ferrara, J.L.M. The primacy of the gastrointestinal tract as a target organ of graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95, 2754-2759 (2000).
14. Morecki, S. et al. Effect of KRN7000 on induced graft-vs-host disease. Exp. Hematol. 32, 630-637 (2004).
15. h2 polarization of donor T cells. J. Immunol. 174, 551-556 (2005).
16. + T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189, 1073-1081 (1999).
17. Pillai, A.B., George, T.I., Dutt, S., Teo, P. & Strober, S. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. J. Immunol. 178, 6242-6251 (2007).
18. Matte, C.C. et al. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10, 987-992 (2004).
19. MacDonald, K.P. et al. Donor pretreatment with progenipoietin-1 is superior to G-CSF in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood 101, 2033-2042 (2003).
20. Morris, E.S. et al. Donor treatment with pegylated G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance. Blood 103, 3573-3581 (2004).
21. Burman, A.C. et al. IFNg differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood 110, 1064-1072 (2007).
22. Rowe, V. et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood 108, 2485-2492 (2006).
23. Westerhof, G.R. et al. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients. Cancer Res. 60, 5470-5478 (2000).
24. + T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002).
25. Hill, G.R. et al. Total body irradiation and acute graft versus host disease. The role of gastrointestinal damage and inflammatory cytokines. Blood 90, 3204-3213 (1997).
26. Cooke, K.R. et al. Tumor necrosis factor-a neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 70, 272-279 (2000).
27. Banovic, T. et al. TGF-b in allogeneic stem cell transplantation: friend or foe? Blood 106, 2206-2214 (2005).
28. Vremec, D., Pooley, J., Hochrein, H., Wu, L. & Shortman, K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978 (2000).
29. Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
30. Hammond, K.J. et al. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. z167, 1164-1173 (2001).